ARDS is a rapidly progressive disease that occurs in critically ill patients. The disease’s most serious complication is that fluid
Read more
Home » Lung Disease »
Upfront, comprehensive genetic testing in advanced lung cancer is cost-effective
An economic model comparing different types of genetic testing in metastatic non-small-cell lung cancer (NSCLC) found that using next-generation sequencing
Read more
Commonly prescribed heartburn drug linked to pneumonia in older adults
Researchers at the University of Exeter have found a statistical link between pneumonia in older people and a group of
Read more
First total penis and scrotum transplant
Many soldiers returning from combat bear visible scars, or even lost limbs, caused by blasts from improvised explosive devices, or
Read more
Size, structure help poziotinib pose threat to deadly exon 20 lung cancer: MD Anderson Lung Cancer Moon Shot™ research matches drug to defiant mutation
A drug that failed to effectively strike larger targets in lung cancer hits a bulls-eye on the smaller target presented
Read more
Is whole-brain radiation still best for brain metastases from small-cell lung cancer?
Lung cancer often metastasizes to the brain. Historically, brain metastases have been treated with whole-brain radiation therapy. However, whole-brain radiation
Read more
Combination therapy doubles survival in metastatic lung cancer: Pembrolizumab and chemotherapy in combination seen as highly effective
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer (NSNSCLC) lacking
Read more
Nanoparticles for lung cancer pass next test
The most common type of lung cancer, non-small cell lung cancer (NSCLC), continues to be difficult to treat, with five
Read more
Two-pronged approach could curb many cases of lung cancer: Metabolic approach halts lung tumors by starving them
Non-small-cell lung cancer, the most common type of lung cancer, is the leading cause of cancer death in the U.S.
Read more